• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一种静脉张力调节药物的临床疗效评估:半合成地奥司明治疗“下肢沉重综合征”的治疗试验经验]

[Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"].

作者信息

Carpentier P H, Mathieu M

机构信息

Laboratoire de Médecine Vasculaire, Université Joseph Fourier, Grenoble.

出版信息

J Mal Vasc. 1998 Apr;23(2):106-12.

PMID:9608923
Abstract

Venous-type symptoms, i.e. painful sensation of heavy, swollen or restless legs, influenced by orthostatism and warm environment, significantly alters quality of life of a large proportion of women. Although the condition is frequently associated with chronic venous insufficiency, no demonstrable hemodynamic abnormality of the superficial as well as deep venous systems of the lower limbs can be found in many patients. The pathogenesis of this syndrome remains unknown, and there is no objective measurement of any biological nor hemodynamic parameters that can be used for its assessment. Diosmine and other flavane derivatives have been shown beneficial in this condition using various discomfort indexes. The aim of this work was to compare the therapeutic efficacy of two formulations of the same compound diosmine. In the analysis, particular attention was paid to the signification and usefulness of discomfort scales. This study was a double-blind, placebo-controlled therapeutic trial, comparing the efficacy of a new formulation, hemisynthesis diosmine 600 mg, one tablet per day taken in the morning, versus the usual tablet formulation of 300 mg taken twice a day (morning and evening). Treatment blindness was assured by the double placebo method. Two parallel groups were treated 28 days with one or the other treatment. Randomization was performed with stratification by center. The main evaluation criteria were a composite scale of venous type symptoms (i.e. the sum of individual score 0-4 of each symptom), and a visual analog auto-evaluation scale quoted each week by the patient. The global opinion of the physician on treatment adequacy to the clinical situation, and the degree of patient satisfaction (four grade scales) were used as subsidiary criteria. In order to increase the homogeneity of the study sample, inclusion was restricted to non-menopaused women aged 18 years and over, having given written informed consent, complaining of distressing sensation of heavy legs, without history of venous thrombosis, varicose veins, superficial or deep venous reflux at the duplex-scan examination. Patients with other causes of pain in the lower limbs, taking analgesic medications or requiring elastic stocking were not included. 255 patients participated in the trial. Eighteen withdrew, equally distributed in both groups (6 lost, 5 interfering diseases, and two dropouts for side effects, namely headache and gastric pain). Twenty additional patients complained of detrimental events not requiring treatment withdrawal, equally distributed between both groups, and mainly involving digestive functions. The results confirmed a similar efficacy of the two drug regimens, and a small but significantly better improvement of the patients' auto-evaluation of their discomfort on the analogic scale (p = 0.021) for hemisynthesis diosmine 600 mg, mainly during the first two weeks; for all four criteria, the gamma risk showed that the once-a-day 600 mg preparation at least as effective as 300 mg twice daily (p < 0.001). On a methodological point of view, the comparison of evaluation criteria showed that the composite scale, although giving the feeling of a comprehensive and quantitative appraisal of the discomfort in the legs, was almost equivalent to a standard four grade rating of heaviness, which appeared as the central symptom of this condition. Auto-evaluation through an analogic scale proved to be more informative, more sensitive, less influenced by the physician's feelings and allow easier assessment of the time-course of the drug's effects. Global evaluations by the patient and the physician did not give additional information but could be used as quality criteria, assessing the coherence of the results obtained with the scales. This study demonstrated a similar efficacy of the two drug regimens, with a more rapid effectiveness of the 600 mg preparation taken once a day. Auto-evaluation on the analog scale proved to be the most informative and effe

摘要

静脉型症状,即腿部沉重、肿胀或不安的疼痛感,受直立姿势和温暖环境影响,显著改变了很大一部分女性的生活质量。尽管这种情况常与慢性静脉功能不全相关,但许多患者下肢浅静脉和深静脉系统均未发现明显的血流动力学异常。该综合征的发病机制尚不清楚,且没有可用于评估的任何生物学或血流动力学参数的客观测量方法。已使用各种不适指数证明地奥司明和其他黄酮衍生物对此病症有益。这项工作的目的是比较同一化合物地奥司明两种制剂的治疗效果。在分析中,特别关注不适量表的意义和有用性。本研究是一项双盲、安慰剂对照治疗试验,比较新制剂半合成地奥司明600毫克(每天早晨服用一片)与通常的300毫克片剂制剂(早晚各服一次)的疗效。采用双安慰剂法确保治疗盲法。两个平行组分别接受其中一种治疗28天。按中心分层进行随机分组。主要评估标准是静脉型症状的综合量表(即每种症状0 - 4分的个体得分总和),以及患者每周引用的视觉模拟自评量表。医生对治疗是否适合临床情况的总体意见以及患者满意度(四级量表)用作次要标准。为了提高研究样本的同质性,纳入标准仅限于18岁及以上未绝经的女性,她们已签署书面知情同意书,主诉腿部沉重的困扰感,且在双功超声检查中无静脉血栓形成、静脉曲张、浅静脉或深静脉反流病史。排除有其他下肢疼痛原因、正在服用止痛药物或需要穿弹力袜的患者。255名患者参与了试验。18名患者退出,两组分布均匀(6名失访,5名有干扰疾病,2名因副作用即头痛和胃痛退出)。另外20名患者抱怨有不良事件但无需停药,两组分布均匀,主要涉及消化功能。结果证实两种药物治疗方案疗效相似,对于半合成地奥司明600毫克,患者在模拟量表上对自身不适的自评有轻微但显著更好的改善(p = 0.021),主要在前两周;对于所有四个标准,伽马风险显示每日一次600毫克制剂至少与每日两次300毫克制剂一样有效(p < 0.001)。从方法学角度来看,评估标准的比较表明,综合量表虽然给人一种对腿部不适进行全面定量评估的感觉,但几乎等同于对沉重感的标准四级评分,而沉重感是这种病症的核心症状。通过模拟量表进行自评被证明更具信息性、更敏感,受医生感觉的影响较小,并且便于评估药物效果的时间进程。患者和医生的总体评估没有提供额外信息,但可作为质量标准,评估通过量表获得的结果的一致性。本研究证明两种药物治疗方案疗效相似,每日一次服用600毫克制剂起效更快。模拟量表自评被证明是最具信息性和有效性的……

相似文献

1
[Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"].[一种静脉张力调节药物的临床疗效评估:半合成地奥司明治疗“下肢沉重综合征”的治疗试验经验]
J Mal Vasc. 1998 Apr;23(2):106-12.
2
[Placebo controlled efficacy of class 1 elastic stockings in chronic venous insufficiency of the lower limbs].[1级弹性长袜对下肢慢性静脉功能不全的安慰剂对照疗效]
J Mal Vasc. 2000 Oct;25(4):256-62.
3
Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.5毫克羟考酮/400毫克布洛芬联合用药治疗女性腹部或盆腔手术后疼痛:一项随机、双盲、安慰剂对照和活性药物对照的平行组研究。
Clin Ther. 2005 Jan;27(1):45-57. doi: 10.1016/j.clinthera.2005.01.010.
4
[A double-blind study comparing the clinical efficacy of the preparation F-117 (hidrosmin) versus diosmin in the treatment of patients with peripheral venous disorders].一项比较制剂F-117(水素明)与地奥司明治疗周围静脉疾病患者临床疗效的双盲研究
Rev Med Univ Navarra. 1990 Apr-Jun;34(2):77-9.
5
[Effects of electrostimulation (Veinoplus) on lower limbs venous insufficiency-related symptoms during pregnancy. Preliminary study].[电刺激(Veinoplus)对孕期下肢静脉功能不全相关症状的影响。初步研究]
Gynecol Obstet Fertil. 2009 Jan;37(1):18-24. doi: 10.1016/j.gyobfe.2008.09.019. Epub 2008 Dec 31.
6
Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form.5682 SE治疗静脉功能不全的药效学和临床活性双盲研究。新型微粉化形式的优势。
Int Angiol. 1989 Oct-Dec;8(4 Suppl):61-5.
7
Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg.临床药理学中显示的促静脉回流特性能否预测对慢性静脉功能不全的治疗益处?我们使用达弗隆500毫克的经验。
Int Angiol. 1989 Oct-Dec;8(4 Suppl):53-9.
8
Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.透皮丁丙诺啡贴剂4天给药方案与3天给药方案的比较:一项单中心、III期、随机、开放标签、交叉对照研究。
Clin Ther. 2007 Aug;29(8):1591-606. doi: 10.1016/j.clinthera.2007.08.001.
9
[Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].[1%长效卡替洛尔每日一次的疗效与安全性。一项双盲随机研究]
J Fr Ophtalmol. 2003 Feb;26(2):131-6.
10
Doxium 500 in chronic venous insufficiency: a double-blind placebo controlled multicentre study.
Int Angiol. 1990 Apr-Jun;9(2):105-10.

引用本文的文献

1
Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.地奥司明与微粒化纯化黄酮类混合物治疗慢性静脉疾病的临床疗效是否存在差异?现有证据回顾。
Vasc Health Risk Manag. 2021 Sep 16;17:591-600. doi: 10.2147/VHRM.S324112. eCollection 2021.
2
Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration.一种新型营养保健品对慢性静脉溃疡患者临床及分子参数的影响。
Int Wound J. 2016 Feb;13(1):88-96. doi: 10.1111/iwj.12240. Epub 2014 Feb 25.